Ron H J Mathijssen - JoVE Visualize

Showing results (111-120 of 335) with videos related to

Pageof 34

Sort By:

Genes|November 30, 2018

Diagnostic and Therapeutic Strategies for Fluoropyrimidine Treatment of Patients Carrying Multiple DPYD VariantsCarin A T C Lunenburg, Linda M Henricks, André B P van Kuilenburg, et al.

European Journal of Cancer (Oxford, England : 1990)|April 16, 2023

Local recurrence in primary localised resected gastrointestinal stromal tumours: A registry observational national cohort study including 912 patientsRoos F Bleckman, Evelyne Roets, Nikki S IJzerman, et al.

Journal of Controlled Release : Official Journal of the Controlled Release Society|June 27, 2020

A phase I dose-escalation and pharmacokinetic study of a micellar nanoparticle with entrapped docetaxel (CPC634) in patients with advanced solid tumoursFlorence Atrafi, Herlinde Dumez, Ron H J Mathijssen, et al.

British Journal of Cancer|February 10, 2025

Pseudo acute kidney injury in patients receiving CDK4/6 inhibitorsSanne M Buijs, Elisabeth M Jongbloed, Lotte E M van Bergen, et al.

ERJ Open Research|December 21, 2019

Tumour growth rate as a tool for response evaluation during PD-1 treatment for non-small cell lung cancer: a retrospective analysisDeirdre M H J Ten Berge, Daniel P Hurkmans, Ilse den Besten, et al.

Drugs & Aging|December 20, 2023

Individualized Dosing Patterns in the Treatment of Older Patients with Gastrointestinal Stromal Tumors: Results of a Registry-Based Observational National Cohort Study Including 871 PatientsRoos F Bleckman, K Esther Broekman, Evelyne Roets, et al.

Cancers|June 16, 2019

Efficacy and Toxicity of Weekly Carboplatin and Paclitaxel as Induction or Palliative Treatment in Advanced Esophageal Cancer PatientsFemke M de Man, Ruben A G van Eerden, Esther Oomen-de Hoop, et al.

The Oncologist|April 5, 2007

Medicinal cannabis does not influence the clinical pharmacokinetics of irinotecan and docetaxelFrederike K Engels, Floris A de Jong, Alex Sparreboom, et al.

Circulation Research|April 1, 2021

Hypertension and Prohypertensive Antineoplastic Therapies in Cancer PatientsDaan C H van Dorst, Stephen J H Dobbin, Karla B Neves, et al.

Breast Cancer Research and Treatment|July 16, 2022

Factors affecting inter-individual variability in endoxifen concentrations in patients with breast cancer: results from the prospective TOTAM trialC Louwrens Braal, Justin D Westenberg, Sanne M Buijs, et al.

Pageof 34

Showing results (111-120 of 335) with videos related to

Sort By:

Pageof 34

Genes|November 30, 2018

Diagnostic and Therapeutic Strategies for Fluoropyrimidine Treatment of Patients Carrying Multiple DPYD VariantsCarin A T C Lunenburg, Linda M Henricks, André B P van Kuilenburg, et al.

European Journal of Cancer (Oxford, England : 1990)|April 16, 2023

Local recurrence in primary localised resected gastrointestinal stromal tumours: A registry observational national cohort study including 912 patientsRoos F Bleckman, Evelyne Roets, Nikki S IJzerman, et al.

Journal of Controlled Release : Official Journal of the Controlled Release Society|June 27, 2020

A phase I dose-escalation and pharmacokinetic study of a micellar nanoparticle with entrapped docetaxel (CPC634) in patients with advanced solid tumoursFlorence Atrafi, Herlinde Dumez, Ron H J Mathijssen, et al.

British Journal of Cancer|February 10, 2025

Pseudo acute kidney injury in patients receiving CDK4/6 inhibitorsSanne M Buijs, Elisabeth M Jongbloed, Lotte E M van Bergen, et al.

ERJ Open Research|December 21, 2019

Tumour growth rate as a tool for response evaluation during PD-1 treatment for non-small cell lung cancer: a retrospective analysisDeirdre M H J Ten Berge, Daniel P Hurkmans, Ilse den Besten, et al.

Drugs & Aging|December 20, 2023

Individualized Dosing Patterns in the Treatment of Older Patients with Gastrointestinal Stromal Tumors: Results of a Registry-Based Observational National Cohort Study Including 871 PatientsRoos F Bleckman, K Esther Broekman, Evelyne Roets, et al.

Cancers|June 16, 2019

Efficacy and Toxicity of Weekly Carboplatin and Paclitaxel as Induction or Palliative Treatment in Advanced Esophageal Cancer PatientsFemke M de Man, Ruben A G van Eerden, Esther Oomen-de Hoop, et al.

The Oncologist|April 5, 2007

Medicinal cannabis does not influence the clinical pharmacokinetics of irinotecan and docetaxelFrederike K Engels, Floris A de Jong, Alex Sparreboom, et al.

Circulation Research|April 1, 2021

Hypertension and Prohypertensive Antineoplastic Therapies in Cancer PatientsDaan C H van Dorst, Stephen J H Dobbin, Karla B Neves, et al.

Breast Cancer Research and Treatment|July 16, 2022

Factors affecting inter-individual variability in endoxifen concentrations in patients with breast cancer: results from the prospective TOTAM trialC Louwrens Braal, Justin D Westenberg, Sanne M Buijs, et al.

Pageof 34